RPS says codeine linctus should be made a prescription-only medicine, in responseto MHRA consultation

摘要

The Medicines and Healthcare products Regulatory Agency launched its consultation after receiving 116 Yellow Card reports ofrecreational drug abuse, dependence and withdrawal relating to codeine medicines — including codeine linctus — since 2018 SHUTTERSTOCK.COM The Royal Pharmaceutical Society (RPS) has said codeine linctus should be reclassified from a pharmacy (P) medicine to a prescription-onlymedicine (POM)